COVID-19 has strained the Indian healthcare sector unlike ever before. While hospitals and healthcare professionals struggle to meet the continuously increasing demand, the pharmaceutical and medical devices industries have been presented with a novel challenge as well as opportunity to develop vaccine and remedial drugs for COVID-19. Concurrently, pharmaceutical companies are also besieged with the need for other critical and essential medication for domestic consumption and exports.

 Author: Neelambera Sandeepan, Joint Partner (L&S)
 Voice: Gunmeher Juneja, Principal Associate (L&S)

 www.lakshmisri.com